Literature DB >> 16499805

Role of Kleihauer test in Rhesus negative pregnancy.

Urooj Mahboob1, Syeda Batool Mazhar.   

Abstract

OBJECTIVE: To determine the role of Kleihauer test in estimating fetomaternal haemorrhage and dose of injection anti-D.
DESIGN: Analytical study. PLACE AND DURATION OF STUDY: MCH Center, Unit-II, PIMS, Islamabad, from February to December 2004. PATIENTS AND METHODS: A hundred Rhesus negative pregnant women delivered after 28 weeks gestation during the study period were studied. The main outcome measures were Kleihauer test estimation of fetomaternal haemorrhage and association of significant fetomaternal haemorrhage with antepartum haemorrhage (APH), amniocentesis, twin delivery, intrauterine death (IUD), external cephalic version (ECV), manual removal of placenta and cesarean section.
RESULTS: Among the hundred women, 28 were primigravidae while 72 were multigravidae. Mean gestational age at delivery was 38.4+/-1.6 weeks. In 24% Rhesus-D negative subjects, potential sensitizing events occurred antenatally. In 11% of these, events occurred before 24 weeks of gestation. Two percent underwent ECV, 10 % had blunt abdominal trauma in third trimester while one patient had APH. Sixty five women had vaginal delivery and cesarean section was performed in 35. Outcome was alive baby in all cases except one intrauterine fetal demise (IUD). Four patients had placenta removed manually. Mean amount of fetomaternal haemorrhage was 2.7+/-1.01 ml (1.2-5.2 ml). The mean anti-D dose required was 67.3+/-25.3 microg. Twenty six women did not need anti-D as they had Rhesus negative infants.
CONCLUSION: In this series routine postnatal Rhesus prophylaxis with 300 microg anti-D immunoglobulin covered all the feto-maternal haemorrhage. Therefore, Kleihauer test with added burden of cost is not indicated as a routine to rhesus negative women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499805     DOI: 2.2005/JCPSP.120123

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  2 in total

1.  The importance of antenatal prevention of RhD immunisation in the first pregnancy.

Authors:  Slavica Dajak; Damir Roje; Željka Hundrić Hašpl; Pera Erceg Maglić
Journal:  Blood Transfus       Date:  2014-01-02       Impact factor: 3.443

2.  Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.

Authors:  J M Koelewijn; M de Haas; T G M Vrijkotte; C E van der Schoot; G J Bonsel
Journal:  BJOG       Date:  2009-06-17       Impact factor: 6.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.